Diabetes – Johns Hopkins Medicine Podcasts

Prediabetes is a condition where your blood sugar is higher than it should be, but not high enough to be called diabetes, and if you’ve been told you have it you can take steps to avoid transitioning to diabetes. That’s …

Can you avoid developing diabetes if you have prediabetes? Elizabeth Tracey reports Read More »

People who have prediabetes frequently go on to develop diabetes, but diabetes prevention programs or DPPs can help. Nas Mathioudakis, a diabetes expert at Johns Hopkins and one developer of an AI based DPP, explains what’s at stake. Nestoras Mathioudakis: …

Diabetes prevention programs may be utilized more with an AI approach, Elizabeth Tracey reports Read More »

Diabetes prevention programs or DPPs were developed by the CDC over a decade ago to help people with prediabetes avoid frank development of diabetes, but very few people access them. Nas Mathioudakis, a diabetes expert at Johns Hopkins and one …

People with prediabetes can benefit from an AI based diabetes prevention program, Elizabeth Tracey reports Read More »

For people with the condition called prediabetes, prevention to full blown diabetes is key. Over a decade ago the CDC developed diabetes prevention programs or DPPs to help but very few people access them. Now a new AI based DPP …

How does AI stack up against human provided diabetes prevention programs? Elizabeth Tracey reports Read More »

Metformin is a older medication used for type 2 diabetes that’s now being evaluated for improving longevity. Another diabetes medicine called a GLP-1 agonist is being used to treat obesity. Diabetes expert Rita Kalyani at Johns Hopkins says possible expanded …

Several diabetes medicines are being eyed for use outside of this condition, Elizabeth Tracey reports Read More »

Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that …

Will everyone soon be taking a medicine first developed to manage type 2 diabetes? Elizabeth Tracey reports Read More »

Diabetes medicine known as GLP-1 agonists and SGLT-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there’s no …

Are certain diabetes medicines best for specific people? Elizabeth Tracey reports Read More »

Let’s say you’ve just been diagnosed with type 2 diabetes, but outside of that condition you have no other health issues. Should you take a newer class of diabetes medicine or will one of the older ones serve you just …

When are newer diabetes medicines best? Elizabeth Tracey reports Read More »

If you have type 2 diabetes, what are the best medicines to manage it? A new meta-analysis looks at aggregated data from a number of studies and comes out in favor of the newer classes of drugs. Rita Kalyani, a …

What are the best medicines to manage diabetes? Elizabeth Tracey reports Read More »

A very common type of virus called an enterovirus has been implicated in the development of type 1 diabetes, according to a new study. Rita Kalyani, a diabetes expert at Johns Hopkins, says the data is gathered from a large …

Is there a virus involved in the development of type 1 diabetes? Elizabeth Tracey reports Read More »